| Adaptation of high-throughput screening in drug discovery—toxicological screening tests P Szymański, M Markowicz, E Mikiciuk-Olasik International journal of molecular sciences 13 (1), 427-452, 2011 | 434 | 2011 |
| Metformin–A future therapy for neurodegenerative diseases: Theme: Drug discovery, development and delivery in Alzheimer's disease Guest Editor: Davide Brambilla M Markowicz-Piasecka, J Sikora, A Szydłowska, A Skupień, ... Pharmaceutical research 34, 2614-2627, 2017 | 249 | 2017 |
| Development of copper based drugs, radiopharmaceuticals and medical materials P Szymański, T Frączek, M Markowicz, E Mikiciuk-Olasik Biometals 25, 1089-1112, 2012 | 196 | 2012 |
| Is metformin a perfect drug? Updates in pharmacokinetics and pharmacodynamics M Markowicz-Piasecka, K M Huttunen, L Mateusiak, E Mikiciuk-Olasik, ... Current pharmaceutical design 23 (17), 2532-2550, 2017 | 112 | 2017 |
| Short-term supplementation with Aronia melanocarpa extract improves platelet aggregation, clotting, and fibrinolysis in patients with metabolic syndrome J Sikora, M Broncel, M Markowicz, M Chałubiński, K Wojdan, ... European Journal of Nutrition 51, 549-556, 2012 | 97 | 2012 |
| Radiolabeled peptides and antibodies in medicine P Kręcisz, K Czarnecka, L Królicki, E Mikiciuk-Olasik, P Szymański Bioconjugate chemistry 32 (1), 25-42, 2020 | 60 | 2020 |
| Nanotechnology in pharmaceutical and biomedical applications: Dendrimers P SZYMAŃSKI, M Markowicz, E MIKICIUK-OLASIK Nano 6 (06), 509-539, 2011 | 60 | 2011 |
| In vitro cultures of Salvia officinalis L. as a source of antioxidant compounds I Grzegorczyk, I Bilichowski, E Mikiciuk-Olasik, H Wysokinska Acta Societatis Botanicorum Poloniae 74 (1), 2005 | 60 | 2005 |
| New perspectives of Alzheimer disease diagnosis–The most popular and future methods K Pietrzak, K Czarnecka, E Mikiciuk-Olasik, P Szymanski Medicinal Chemistry 14 (1), 34-43, 2018 | 56 | 2018 |
| Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors P Szymański, M Markowicz, E Mikiciuk-Olasik Bioorganic Chemistry 39 (4), 138-142, 2011 | 49 | 2011 |
| Evaluation of poly (amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy M Markowicz, P Szymański, M Ciszewski, A Kłys, E Mikiciuk-Olasik Journal of biological physics 38, 637-656, 2012 | 48 | 2012 |
| Extract of Aronia melanocarpa-modified hemostasis: in vitro studies J Sikora, M Markowicz-Piasecka, M Broncel, E Mikiciuk-Olasik European journal of nutrition 53, 1493-1502, 2014 | 47 | 2014 |
| Metabolite Profiling of Eastern Teaberry (Gaultheria procumbens L.) Lipophilic Leaf Extracts with Hyaluronidase and Lipoxygenase Inhibitory Activity P Michel, A Owczarek, M Matczak, M Kosno, P Szymański, ... Molecules 22 (3), 412, 2017 | 45 | 2017 |
| Biological approach of anticancer activity of new benzimidazole derivatives K Błaszczak-Świątkiewicz, P Olszewska, E Mikiciuk-Olasik Pharmacological Reports 66, 100-106, 2014 | 43 | 2014 |
| Aronia melanocarpa Elliot reduces the activity of angiotensin I-converting enzyme—in vitro and ex vivo studies J Sikora, M Broncel, E Mikiciuk-Olasik Oxidative Medicine and Cellular Longevity 2014, 2014 | 39 | 2014 |
| Studies towards biocompatibility of PAMAM dendrimers–overall hemostasis potential and integrity of the human aortic endothelial barrier M Markowicz-Piasecka, E Łuczak, M Chałubiński, M Broncel, ... International Journal of Pharmaceutics 473 (1-2), 158-169, 2014 | 37 | 2014 |
| 2,3-Dihydro-1H-cyclopenta[b]quinoline Derivatives as Acetylcholinesterase Inhibitors—Synthesis, Radiolabeling and Biodistribution P Szymański, A Lázničková, M Lázniček, M Bajda, B Malawska, ... International Journal of Molecular Sciences 13 (8), 10067-10090, 2012 | 35 | 2012 |
| Synthesis, biological activity and HPLC validation of 1, 2, 3, 4-tetrahydroacridine derivatives as acetylcholinesterase inhibitors P Szymanski, A Karpiński, E Mikiciuk-Olasik European journal of medicinal chemistry 46 (8), 3250-3257, 2011 | 35 | 2011 |
| Synthesis, biological activity and HPLC validation of 1, 2, 3, 4-tetrahydroacridine derivatives as acetylcholinesterase inhibitors P Szymanski, A Karpiński, E Mikiciuk-Olasik European journal of medicinal chemistry 46 (8), 3250-3257, 2011 | 35 | 2011 |
| Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease M Bajda, J Jończyk, B Malawska, K Czarnecka, M Girek, P Olszewska, ... Bioorganic & Medicinal Chemistry 23 (17), 5610-5618, 2015 | 33 | 2015 |
